Small Caps expert Tim Boreham's (he is one of Australia’s best-known small cap analysts and business journalists) * article 28 January 2018 (https://unauthorised investment adv...al&utm_source=twitter.com&utm_campaign=buffer)
* Undervalued -Dr Bill Ketelbey reckons that, globally, a phase II Alzheimer’s triallist attracts an average market valuation of $US800 million (AU$992 million). Given Actinogen’s lowly $30 million market cap, he contends the company is undervalued.
* Xanadu and beyond - Xanamem’s opportunities lie with diabetes-related cognitive impairment, post-traumatic stress disorder, Parkinson’s disease, epilepsy, schizophrenia and post myocardial infarction.All of these are related to elevated levels of the cortisol “stress hormone”.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Small Caps expert Tim Boreham's (he is one of Australia’s...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
3.6¢ |
Change
-0.003(7.69%) |
Mkt cap ! $97.64M |
Open | High | Low | Value | Volume |
3.7¢ | 3.9¢ | 3.6¢ | $151.2K | 4.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 3271718 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 125725 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 3271718 | 0.036 |
8 | 1397927 | 0.035 |
1 | 15000 | 0.034 |
2 | 210058 | 0.033 |
2 | 216688 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 125725 | 3 |
0.038 | 409101 | 5 |
0.039 | 937147 | 6 |
0.040 | 436128 | 7 |
0.041 | 723649 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |